Julie Segre, Ph.D. is a Senior Investigator at the National Human Genome Research Institute, NIH Intramural Research Program. Her research focuses on the human microbiome, investigating both the transmission of hospital pathogens and the diversity of commensal skin organisms, including bacteria, fungi and viruses. Segre’s research integrates DNA sequence technology, algorithm development and clinical studies to explore the diversity of microbes in and on humans in health and disease. Tracking multi-drug resistant organisms in healthcare ecosystems, her current research focuses on the emerging fungal pathogen Candida auris.
Segre is committed to scientific communities that recognize, integrate and champion equity, diversity and inclusion. She recognizes that diversity is a key driver of scientific creativity and innovation and invests in institution-centered approaches that will change the culture of science to ensure that all individuals feel they belong in science and that the institutions work toward their success.
- Elected National Academy of Sciences, 2022
- Elected American Academy of Arts and Sciences, 2020
- Elected National Academy of Medicine, 2019
- Elected Fellow of American Academy of Microbiology, 2015
- Service to America Medal Federal Employee of the Year, Highest Honor for civilian federal employee, 2013
- Saheb Kashaf S, Proctor DM, Deming C, Saary P, Hoelzer M, NISC CompSeqProgram, Taylor ME, Kong HH, Segre JA*, Almeida A*, Finn RD* (2022) Integrating cultivation and metagenomics for a multi-kingdom view of skin microbiome diversity and functions. Nat Microbiology. Jan;7(1):169-179
- Huang X, Hurabielle C, Drummond RA, Bouladoux N, Desai JV, Sim CK, Belkaid Y, Lionakis MS*, Segre JA* (2021). Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and intervention strategies. Cell Host Microbe. Feb 10;29(2):210-221.
- Proctor DM, Dangana T, Sexton DJ, …, Lin MY, Schoeny MD, Litvintseva AP, Segre JA*, Hayden MK* (2021). Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility. Nat Med. Aug;27(8):1401-1409.
CIFAR is a registered charitable organization supported by the governments of Canada, Alberta and Quebec, as well as foundations, individuals, corporations and Canadian and international partner organizations.